TNFA-L
|
Diffuse Large B Cell Lymphoma
|
TNFA-L
|
Diffuse Large B Cell Lymphoma
|
relmacabtagene autoleucel Sensitive: C3 – Early Trials
|
relmacabtagene autoleucel Sensitive: C3 – Early Trials
|
TNFA-L
|
Cholangiocarcinoma
|
TNFA-L
|
Cholangiocarcinoma
|
bexmarilimab Sensitive: C3 – Early Trials
|
bexmarilimab Sensitive: C3 – Early Trials
|
TNFA-L
|
Melanoma
|
TNFA-L
|
Melanoma
|
bexmarilimab Sensitive: C3 – Early Trials
|
bexmarilimab Sensitive: C3 – Early Trials
|
TNFA-L
|
Gastric Cancer
|
TNFA-L
|
Gastric Cancer
|
bexmarilimab Sensitive: C3 – Early Trials
|
bexmarilimab Sensitive: C3 – Early Trials
|